IMAB
Price
$2.11
Change
-$0.01 (-0.47%)
Updated
Jul 25 closing price
Capitalization
172.3M
37 days until earnings call
INDP
Price
$9.92
Change
+$0.03 (+0.30%)
Updated
Jul 25 closing price
Capitalization
5.68M
22 days until earnings call
Interact to see
Advertisement

IMAB vs INDP

Header iconIMAB vs INDP Comparison
Open Charts IMAB vs INDPBanner chart's image
I-MAB
Price$2.11
Change-$0.01 (-0.47%)
Volume$105.96K
Capitalization172.3M
Indaptus Therapeutics
Price$9.92
Change+$0.03 (+0.30%)
Volume$12.04K
Capitalization5.68M
IMAB vs INDP Comparison Chart in %
Loading...
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMAB vs. INDP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMAB is a Hold and INDP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMAB: $2.11 vs. INDP: $9.92)
Brand notoriety: IMAB and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMAB: 15% vs. INDP: 3%
Market capitalization -- IMAB: $172.3M vs. INDP: $5.68M
IMAB [@Biotechnology] is valued at $172.3M. INDP’s [@Biotechnology] market capitalization is $5.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMAB’s FA Score shows that 0 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • IMAB’s FA Score: 0 green, 5 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, IMAB is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMAB’s TA Score shows that 4 TA indicator(s) are bullish while INDP’s TA Score has 5 bullish TA indicator(s).

  • IMAB’s TA Score: 4 bullish, 4 bearish.
  • INDP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IMAB and INDP are a good buy in the short-term.

Price Growth

IMAB (@Biotechnology) experienced а +0.48% price change this week, while INDP (@Biotechnology) price change was -14.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

IMAB is expected to report earnings on Sep 02, 2025.

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMAB($172M) has a higher market cap than INDP($5.68M). IMAB YTD gains are higher at: 148.235 vs. INDP (-57.928). INDP has less debt than IMAB: INDP (59.5K) vs IMAB (3.68M).
IMABINDPIMAB / INDP
Capitalization172M5.68M3,028%
EBITDA-46.92MN/A-
Gain YTD148.235-57.928-256%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash169MN/A-
Total Debt3.68M59.5K6,192%
FUNDAMENTALS RATINGS
INDP: Fundamental Ratings
INDP
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMABINDP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 19 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMMCF0.180.01
+3.45%
Pampa Metals Corporation
DSCSY29.770.97
+3.37%
Disco Corp.
PHJMF0.04N/A
N/A
PT Hanjaya Mandala Sampoerna Terbuka
MJDLF6.79-0.11
-1.61%
Major Drilling Group International Inc.
SMAGF0.91-0.06
-6.29%
Soma Gold Corp.

IMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMAB has been loosely correlated with INDP. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IMAB jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMAB
1D Price
Change %
IMAB100%
-0.47%
INDP - IMAB
39%
Loosely correlated
+0.30%
RPRX - IMAB
31%
Poorly correlated
+0.22%
ALT - IMAB
31%
Poorly correlated
N/A
CGEN - IMAB
27%
Poorly correlated
-0.65%
KPRX - IMAB
27%
Poorly correlated
-1.97%
More

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
+0.30%
UNCY - INDP
52%
Loosely correlated
+0.41%
ALT - INDP
45%
Loosely correlated
N/A
CDTX - INDP
40%
Loosely correlated
-1.54%
IMAB - INDP
39%
Loosely correlated
-0.47%
RVPH - INDP
30%
Poorly correlated
+9.63%
More